1955 Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Craifcraif.cominOct 2021
Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
AI & Machine LearningBiotechHealthtechMedical DevicesTokyo, JP
Ryuichi Onose(Executive Officer, Director)inYuki Ichikawa(Director)Mika Yui(Director)
Co-investorsGlobal BrainAozora Corporate Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.